Projects

Selected Industry Projects

  • Antihypertensive agents: amlodipine, ramipril – Phase 3 reports
  • Anti-infectives: azithromycin, linezolid – Phase 3 reports, quality control
  • Antiplatelet agent: clopidogrel – Phase 1 reports
  • Antithrombotic: factor Xa inhibitor – Phase 1 reports
  • Breast cancer: fulvestrant – Informed consent document
  • Diabetes: troglitazone – Phase 3 reports
  • Esophageal cancer: nimotuzumab – Protocol
  • Global Innovate!! implementation of progressive business ideas
  • Hormone replacement: norethindrone acetate/ethinyl estradiol – Phase 3 reports
  • Hypercholesterolemia: torcetrapib / atorvastatin – Phase 2 reports
  • Neuropathic pain: gabapentin, pregabalin – Phase 3 reports, safety narratives
  • Renal disease: mycophenolate sodium – Protocol
  • Selective estrogen receptor modulator (SERM): lasofoxifene – Phase 2/3 reports
  • Smoking cessation: varenicline – Phase 3 reports
  • Workshops: Clinical Study Reports, GCP, ICH and the Declaration of Helsinki, Informed Consent, Search Strategies, Statistics in Medicine.

Leave a Reply

Your email address will not be published. Required fields are marked *